Loxo Oncology Competitors and Similar CompaniesClear all
Loxo Oncology's competitors and similar companies include Repare Therapeutics, Janssen, Ascentage Pharma and Chugai Pharmaceutical.
 Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. |  Repare Therapeutics Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells. |  Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. |  Chugai Pharmaceutical Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2016 | Founding Date 1953 | Founding Date 2017 | Founding Date 1925 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US | Locations Montréal, CA HQ Cambridge, US | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations Chuo City, JP HQ Guangzhou Shi, CN Taizhou, CN Puteaux, FR Frankfurt Am Main, DE Singapore, SG see more | |
Employees | Employees 65610% decrease | Employees 129 | Employees 17,3684% decrease | Employees 567 | Employees 7,778 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 152.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 78.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $53.5m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) ¥1.3t (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥48.9m (FY, 2025) | Cost of goods ¥363.7b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $53.5m (FY, 2024) | Gross profit N/A | Gross profit ¥546.6m (FY, 2025) | Gross profit ¥903.5b (FY, 2025) |
Net income | Net income ($148.9m) (FY, 2017) | Net income ($84.7m) (FY, 2024) | Net income N/A | Net income (¥1.2b) (FY, 2025) | Net income ¥434b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 57m | Total funding raised $ 150.5m | Total funding raised N/A | Total funding raised $ 237.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Repare Therapeutics
HQ
Montréal, CA
Employees
129
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
View company
Janssen
HQ
Raritan, US
Janssen is a company providing prescription pharmaceutical products.
View companyAscentage Pharma
HQ
Suzhou, CN
Employees
567
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View companyChugai Pharmaceutical
HQ
Chuo City, JP
Employees
7,778
Chugai Pharmaceutical is a pharmaceutical company specializing in the fields of oncology, as well as bone, joint, and renal diseases.
View company